RE:RE:RE:RE:RE:RE:RE:RE:i-Dialco Ha. I can't help much with BSW as I posted that I put him on "ignore" back in Oct. adding: "Can't you see that the whole premise for you bash and your credibility just crumble with your obvious lies?"
On EMH.. the Share Price doesn't reflect known information- it reflects Spectral's management.
It reflects their inability to ever start the DIMI trial, or to enroll promised numbers into the Tigris trial, It reflects Seto being more than 1 yr off on reaching 60% (and counting), it reflects their lack of transparency- like in the Baxter deal- or even Baxter being part of the financing.. it reflects the witholding of who "confirmed partner #2" was, or that they had not fulfilled the Infomed contract back in June..
At present, management is fine with their only analyst and shareholders believing their Dialco investments are now worth zero.
So when you look at that track record I'd say .33 is probably fair. Our science is solid and should be worth many dollars- but the way Seto and Co. are running the show makes it high risk. As their loss of control of Dialco has just shown us.